-
Trial Shows Treatment Desensitizes Peanut Allergies
A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year.
-
Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal
Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease.
-
RNA Vaccine Shows Promise with Infant Viral Diseases
A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients.
-
Embracing Technology for Better Business Efficiency
Finding technology that works to make your office more efficient in all aspects, from trading to productivity to saving money is essential towards achieving further growth in your company.
-
Scenes from the AAAS Annual Meeting
There’s more going on at the AAAS meeting than papers and presentations, including Family Science Days, always a big hit with kids of all ages.
-
Gut Tissue From Stem Cells Simulated on Organ Chips
Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients.
-
Alexa, How Will Amazon Echo Affect My Business?
What on earth is the IoT, you ask? Well, it’s a digital presence connecting everyday household items and the internet.
-
NIH Exec: Research Offers Opioid Crisis Solutions
The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths.
-
Cancer Analytics Company Acquired in $1.9B Deal
The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion.
-
Going to Austin, City with No Limits
Science & Enterprise is headed to Austin, Texas to cover the annual meeting of American Association for the Advancement of Science, or AAAS, and we will report from the meeting from Friday through Sunday.